Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Sculpture
D258945 Sculpture
Patent Drawings:Drawing: D258945-2    
« 1 »

(1 images)

Inventor: Gabriella
Date Issued: April 21, 1981
Application: 05/874,927
Filed: August 25, 1978
Inventors: Gabriella; Rocco M. (Willingboro, NJ)
Assignee:
Primary Examiner: Zarfas; Louis S.
Assistant Examiner:
Attorney Or Agent: Ceasar, Rivise, Bernstein & Cohen, Ltd.
U.S. Class: D11/161
Field Of Search: D11/53; D11/83; D11/101; D11/136; D11/160; D11/161; D6/106; D6/108; D6/109; D6/110; 63/1A; 63/20; 63/21; 63/23; 428/16; 428/43; D21/149; 46/156
International Class:
U.S Patent Documents: D74106; D106058; D148558; D175882; D252776
Foreign Patent Documents:
Other References:









Abstract:
Claim: The ornamental design for a sculpture, substantially as shown and described.
Description: FIG. 1 is a front elevational view of a sculpture showing my new design; and,

FIG. 2 is a side elevational view thereof, both sides being the same.

The rear of the sculpture is flat and unadorned.

* * * * *
 
 
  Recently Added Patents
Wheel
Method for detection and characterization of a microorganism in a sample using time-dependent intrinsic fluorescence measurements
Micromechanical component, device for beam deflection of monochromatic light, and spectrometer
Compact bus bar assembly, switching device and power distribution system
Display apparatus, a method for a display control, and program
Signal processing apparatus, display apparatus having the same, and signal processing method
Method of producing probabilities of being a template shape
  Randomly Featured Patents
Diagnosis system with identification display device
Process for determination of fat content
Food roaster
Endosurgical extraction bag for collecting body tissue or body fluid
Method of operating an electrostatic precipitator
Manipulation of data
Ski with non-symmetrical running surface
Removal of adenine during a pathogen reduction process in whole blood or red blood cells by dilution
Power shift transmission
1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2